CsTrx80, a truncated form of thioredoxin, possesses chemokine-like property and enhances the immune defense of Cynoglossus semilaevis against bacterial infection

Fish and Shellfish Immunology

Volumn 35, Issue 6, 2013, Pages 2026-2031

  Li, Mo fei ^a,b   Chen, Cheng ^a,b   Sun, Bo guang ^a   Sun, Li ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Chemotaxis; Cynoglossus semilaevis; Immunoregulatory; Thioredoxin

Indexed keywords

BACTERIA (MICROORGANISMS); CYNOGLOSSIDAE; CYNOGLOSSUS SEMILAEVIS; ESCHERICHIA COLI;

CHEMOKINE; FISH PROTEIN; RECOMBINANT PROTEIN; THIOREDOXIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMOTAXIS; CYNOGLOSSUS SEMILAEVIS; EDWARDSIELLA TARDA; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FISH DISEASE; FLATFISH; GENE EXPRESSION REGULATION; GENETICS; HEAD KIDNEY; IMMUNOLOGY; IMMUNOREGULATORY; METABOLISM; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHEMOTAXIS; CYNOGLOSSUS SEMILAEVIS; IMMUNOREGULATORY; THIOREDOXIN;

ANIMALS; CHEMOKINES; CHEMOTAXIS; EDWARDSIELLA TARDA; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FISH DISEASES; FISH PROTEINS; FLATFISHES; GENE EXPRESSION REGULATION; HEAD KIDNEY; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOREDOXINS;

EID: 84888430335     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2013.10.013     Document Type: Article

References (28)

1. Holmgren A. Thioredoxin. Annu Rev Biochem 1985, 54:237-271.
2. Powis G., Montfort W.R. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 2001, 4:261-295.
3. Bertini R., Howard O.M., Dong H.F., Oppenheim J.J., Bizzarri C., Sergi R., et al. Thioredoxin a redox enzyme released in infection and inflammation is a unique chemoattractant for neutrophils monocytes and T cells. JExp Med 1999, 189:1783-1789.
4. Arnér E.S.J., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000, 267:6102-6109.
5. Silberstein D.S., McDonough S., Minkoff M.S., Balcewicz-Sablinska M.K. Human eosinophil cytotoxicity-enhancing factor. Eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions. JBiol Chem 1993, 268:9138-9142.
6. Sahaf B., Rosén A. Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes. Antioxid Redox Signal 2000, 2:717-726.
7. Sahaf B., Söderberg A., Spyrou G., Barral A.M., Pekkari K., Holmgren A., et al. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp Cell Res 1997, 236:181-192.
8. Pekkari K., Holmgren A. Truncated thioredoxin: physiological functions and mechanism. Antioxid Redox Signal 2004, 6:53-61.
9. Pekkari K., Gurunath R., Arner E.S., Holmgren A. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. JBiol Chem 2000, 275:37474-37480.
10. Pekkari K., Avila-Carino J., Bengtsson A., Gurunath R., Scheynius A., Holmgren A. Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 2001, 97:3184-3190.
11. Pekkari K., Avila-Carino J., Gurunath R., Bengtsson A., Scheynius A., Holmgren A. Truncated thioredoxin (Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxido-reductase activity. FEBS Lett 2003, 539:143-148.
12. Khayat M., Stuge T.B., Wilson M., Bengtén E., Miller N.W., Clem L.W. Thioredoxin acts as a B cell growth factor in channel catfish. JImmunol 2001, 166:2937-2943.
13. Kim D.H., Kim J.W., Jeong J.M., Park H.J., Park C.I. Molecular cloning and expression analysis of a thioredoxin from rock bream, Oplegnathus fasciatus, and biological activity of the recombinant protein. Fish Shellfish Immunol 2011, 31:22-28.
14. Park C.I., Jung J.H., Shim W.J., Kim J.W., Kim E.G., Jeong J.M., et al. Molecular characterization, expression, and functional analysis of two thioredoxins in the black rockfish (Sebastes schlegelii). Fish Shellfish Immunol 2012, 32:808-815.
15. Wei J., Guo M., Ji H., Yan Y., Ouyang Z., Huang X., et al. Cloning, characterization, and expression analysis of a thioredoxin from orange-spotted grouper (Epinephelus coioides). Dev Comp Immunol 2012, 38:108-116.
16. Sun J.S., Li Y.X., Sun L. Cynoglossus semilaevis thioredoxin: a reductase and an antioxidant with immunostimulatory property. Cell Stress Chaperones 2012, 17:445-455.
17. Hu Y., Zheng W., Sun L. Identification and molecular analysis of a ferritin subunit from red drum (Sciaenops ocellatus). Fish Shellfish Immunol 2010, 28:678-686.
18. Hu Y.H., Liu C.S., Hou J.H., Sun L. Identification, characterization, and molecular application of a virulence-associated autotransporter from a pathogenic Pseudomonas fluorescens strain. Appl Environ Microbiol 2009, 75:4333-4340.
19. Li Y., Sun J., Sun L. An inflammatory CC chemokine of Cynoglossus semilaevis is involved in immune defense against bacterial infection. Fish Shellfish Immunol 2011, 31:446-452.
20. Zheng W., Sun L. Evaluation of housekeeping genes as references for quantitative real time RT-PCR analysis of gene expression in Japanese flounder (Paralichthys olivaceus). Fish Shellfish Immunol 2011, 30:638-645.
21. Li Y., Hu Y., Sun J., Sun L. CsCXCe1: a novel Cynoglossus semilaevis CXC chemokine that functions as a chemoattractant and an immunomodulator for peripheral blood leukocytes. Dev Comp Immunol 2012, 37:54-64.
22. Zhang M., Jiao X.D., Hu Y.H., Sun L. Attenuation of Edwardsiella tarda virulence by small peptides that interfere with luxs/autoinducer type 2 quorum sensing. Appl Environ Microbiol 2009, 75:3882-3890.
23. King B.C., Nowakowska J., Karsten C.M., Köhl J., Renström E., Blom A.M. Truncated and full-length thioredoxin-1 have opposing activating and inhibitory properties for human complement with relevance to endothelial surfaces. JImmunol 2012, 188:4103-4112.
24. Hofer S., Rosenhagen C., Nakamura H., Yodoi J., Bopp C., Zimmermann J.B., et al. Thioredoxin in human and experimental sepsis. Crit Care Med 2009, 37:2155-2159.
25. Inomata Y., Tanihara H., Tanito M., Okuyama H., Hoshino Y., Kinumi T., et al. Suppression of choroidal neovascularization by thioredoxin-1 via interaction with complement factor H. Invest Ophthalmol Vis Sci 2008, 49:5118-5125.
26. Tao L., Gao E., Bryan N.S., Qu Y., Liu H.R., Hu A., et al. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc Natl Acad Sci 2004, 101:11471-11476.
27. Zhang J., Chen F., Nakamura T., Fujinaga T., Aoyama A., Hamakawa H., et al. Protective effect of thioredoxin perfusion but not inhalation in warm ischemic-reperfused rat lungs. Redox Rep 2009, 14:75-81.
28. Cortes-Bratti X., Bassères E., Herrera-Rodriguez F., Botero-Kleiven S., Coppotelli G., Andersen J.B., et al. Thioredoxin 80-activated-monocytes (TAMs) inhibit the replication of intracellular pathogens. PLoS One 2011, 6:16960.